4.7 Review

HSP47: A Therapeutic Target in Pulmonary Fibrosis

Related references

Note: Only part of the references are listed.
Review Medicine, Research & Experimental

RAGE pathways play an important role in regulation of organ fibrosis

Jing Liu et al.

Summary: Organ fibrosis is a common endpoint of many organ pathologies, characterized by fibroblast activation and excessive deposition of extracellular matrix. The receptor for advanced glycation end products (RAGE) has emerged as an important candidate involved in inflammation, cell proliferation, apoptosis, and angiogenesis related to fibrosis. This review aims to provide comprehensive information about the function of RAGE and its signaling cascades in the pathogenesis of fibrotic diseases, as well as potential strategies for targeting RAGE in fibrosis.

LIFE SCIENCES (2023)

Review Biotechnology & Applied Microbiology

The application of nanomedicine in clinical settings

Qingsong Zhao et al.

Summary: As nanotechnology advances in various fields, including mechanical engineering, electrical engineering, information and communication, and medical care, it holds great potential. Recent developments in medical nanorobots, such as nanomedicine, have shown progress in material selection, fabrication methods, driving force sources, and clinical applications. These nanorobots have the ability to deliver drugs directly to target cells and lesions, enhancing drug concentration and proving useful in monitoring disease progression, complementary diagnosis, and minimally invasive surgery. The study also explores the development and applications of nanomedicine in treating major diseases, providing a summary and discussion of current research for future advancements in the field.

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2023)

Review Biochemistry & Molecular Biology

Fighting the Fiber: Targeting Collagen in Lung Fibrosis

Claudia A. Staab-Weijnitz

Summary: Organ fibrosis is a disease characterized by epithelial injury and abnormal tissue repair, resulting in excessive deposition of collagen. It frequently leads to organ failure and is estimated to be responsible for one-third of global deaths. This review summarizes recent advances in targeting collagen biosynthesis, maturation, and degradation for the treatment of fibrotic diseases. The potential therapeutic targets and their specificity for collagen biology and disease-associated collagen are discussed, along with strategies for targeted drug delivery.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2022)

Article Oncology

Heat shock protein 47 promotes cell migration and invasion through AKT signal in non-small cell lung cancer

Wei Wu et al.

Summary: The study found that HSP47 is highly expressed in non-small cell lung cancer (NSCLC), and inhibiting HSP47 can reduce cell migration and invasion by diminishing the AKT signal. In vivo experiments showed that inhibition of HSP47 has strong therapeutic effects on NSCLC.

ANTI-CANCER DRUGS (2022)

Review Cell Biology

Heat shock proteins in pulmonary fibrosis: pawns of cell homeostasis

Willy Roque

Summary: This review examines the roles of specific heat shock proteins (HSPs), including HSP90, HSP70, and HSP47, in the pathogenesis of idiopathic pulmonary fibrosis (IPF). Understanding the functions of these HSPs in the development of IPF can provide valuable insights for the future treatment and prevention of IPF.

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2022)

Article Critical Care Medicine

Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline

Ganesh Raghu et al.

Summary: This article provides updates on the guidelines for idiopathic pulmonary fibrosis (IPF) and addresses the progression of pulmonary fibrosis in patients with interstitial lung diseases (ILDs) other than IPF. The recommendations are based on consensus and systematic reviews, aiming to provide evidence-based guidance for clinicians.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)

Article Pharmacology & Pharmacy

Nanostructures for drug delivery in respiratory diseases therapeutics: Revision of current trends and its comparative analysis

Luis Angel Ibarra-Sanchez et al.

Summary: Respiratory diseases are a major cause of death and disability globally, and nanotechnology shows promise in improving drug delivery and treatment outcomes. While progress has been made in cancer therapies, recent research has focused on the application of nanotechnology in other pulmonary diseases. The integration of different nanostructures may improve drug bioavailability, transport, and delivery compared to traditional respiratory therapy.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2022)

Review Biochemistry & Molecular Biology

Insights on Human Small Heat Shock Proteins and Their Alterations in Diseases

B. Tedesco et al.

Summary: The family of HSPBs plays a crucial role in maintaining proteostasis and cellular homeostasis in response to stress and apoptosis. They prevent protein aggregation, promote refolding, and can be associated with various diseases when mutations occur. High expression levels of HSPBs are found in cardiac muscle, skeletal muscle, and neurons, and mutations in specific HSPBs can lead to cardiomyopathies, myopathies, and cataract.

FRONTIERS IN MOLECULAR BIOSCIENCES (2022)

Review Medicine, Research & Experimental

Targeting HSP47 and HSP70: promising therapeutic approaches in liver fibrosis management

Eslam E. Abd El-Fattah et al.

Summary: This article discusses the impact of heat shock proteins HSP70 and HSP47 on liver fibrosis, with HSP70 reducing protein aggregation and HSP47 promoting collagen synthesis. Additionally, the article explores potential therapeutic approaches targeting HSP70 and HSP47 as drug candidates for treating liver fibrosis.

JOURNAL OF TRANSLATIONAL MEDICINE (2022)

Article Respiratory System

High SERPINH1 expression predicts poor prognosis in lung adenocarcinoma

Hailing Zhang et al.

Summary: This study demonstrates that SERPINH1 holds important clinical value as a prognostic biomarker in lung adenocarcinoma (LUAD). Additionally, it reveals potential molecular mechanisms of SERPINH1 and provides new approaches and strategies for the clinical treatment of LUAD patients.

JOURNAL OF THORACIC DISEASE (2022)

Review Pharmacology & Pharmacy

Research Progress in the Molecular Mechanisms, Therapeutic Targets, and Drug Development of Idiopathic Pulmonary Fibrosis

Hongbo Ma et al.

Summary: Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease with various factors contributing to its development, including cell dysregulation, genetic mutations, environmental factors, and epigenetics. Recent clinical trials have led to the discovery of novel therapeutic targets and drugs for IPF.

FRONTIERS IN PHARMACOLOGY (2022)

Article Medicine, Research & Experimental

Investigating the possible mechanisms of pirfenidone to be targeted as a promising anti-inflammatory, anti-fibrotic, anti-oxidant, anti-apoptotic, anti-tumor, and/or anti-SARS-CoV-2

Samar A. Antar et al.

Summary: Pirfenidone (PFD) is a synthetic chemical that inhibits the production of various substances, potentially offering anti-inflammatory, anti-fibrotic, antioxidant, anti-apoptotic, anti-tumor, and/or anti-SARS-CoV-2 properties.

LIFE SCIENCES (2022)

Review Cell Biology

The Role of SIRT3 in Exercise and Aging

Lei Zhou et al.

Summary: The health benefits of regular exercise are well-established, but the molecular mechanisms behind these benefits are still debated. SIRT3, a key cell-signaling candidate, has been proposed to provide exercise-induced benefits. However, studies on the impact of exercise on SIRT3 abundance in cells have conflicting results. This narrative review analyzes the role of exercise-induced changes in SIRT3 in providing the health and aging benefits associated with regular physical activity, and raises important unanswered questions for future research.

CELLS (2022)

Review Pharmacology & Pharmacy

HSP47: a potential target for fibrotic diseases and implications for therapy

Pierre-Simon Bellaye et al.

Summary: As a collagen-specific chaperon, HSP47 shows promising therapeutic potential in fibrosis. Preclinical models have demonstrated encouraging anti-fibrotic effects. Further evaluation of anti-HSP47 strategies in clinical trials is warranted.

EXPERT OPINION ON THERAPEUTIC TARGETS (2021)

Article Medicine, General & Internal

Silencing Heat Shock Protein 47 (HSP47) in Fibrogenic Precision-Cut Lung Slices: A Surprising Lack of Effects on Fibrogenesis?

Mitchel J. R. Ruigrok et al.

Summary: IPF is a chronic lung disease with an urgent need for more effective drugs, with HSP47 identified as a potential therapeutic target. Targeted siRNA therapy against Serpinh1 showed reduction in fibronectin secretion in fibrotic lung slices, indicating a promising approach for fibrosis treatment.

FRONTIERS IN MEDICINE (2021)

Article Multidisciplinary Sciences

Sensitization of the UPR by loss of PPP1R15A promotes fibrosis and senescence in IPF

Susan Monkley et al.

Summary: Targeting PPP1R15A can modulate TGF-beta-induced fibroblast to myofibroblast differentiation and exacerbate pulmonary fibrosis in bleomycin-challenged mice. The loss of PPP1R15A appeared to promote lung fibroblast senescence.

SCIENTIFIC REPORTS (2021)

Review Medicine, General & Internal

Efficacy and safety of pirfenidone in the treatment of idiopathic pulmonary fibrosis patients: a systematic review and meta-analysis of randomised controlled trials

Wenjuan Wu et al.

Summary: Pirfenidone shows significant efficacy in treating IPF, providing survival benefit and prolonging progression-free survival for patients. It is also associated with a lower incidence of acute exacerbation and worsening of IPF.

BMJ OPEN (2021)

Article Chemistry, Medicinal

Screening of Inhibitors Targeting Heat Shock Protein 47 Involved in the Development of Idiopathic Pulmonary Fibrosis

Daisuke Okuno et al.

Summary: The study prepared human HSP47 and established an inhibitor screening system. Among the compounds screened, three were found to effectively inhibit the function of HSP47, with epigallocatechin-3-O-gallate from tea leaves being one of them.

CHEMMEDCHEM (2021)

Review Genetics & Heredity

The interplay of DAMPs, TLR4, and proinflammatory cytokines in pulmonary fibrosis

Siavash Bolourani et al.

Summary: Pulmonary fibrosis is a chronic condition characterized by progressive deposition of connective tissue, leading to a decline in lung elasticity and function. Common causes include inhalation of foreign particles, infections, autoimmune diseases, and idiopathic pulmonary fibrosis. Current therapeutics only modestly slow disease progression. This review focuses on the interplay of DAMP molecules, TLR4, and inflammatory cytokines in the pathogenesis of pulmonary fibrosis and explores potential avenues for developing effective therapeutics.

JOURNAL OF MOLECULAR MEDICINE-JMM (2021)

Article Respiratory System

Anti-HSP47 siRNA lipid nanoparticle ND-L02-s0201 reverses interstitial pulmonary fibrosis in preclinical rat models

Yun Liu et al.

Summary: ND-L02-s0201, a lipid nanoparticle encapsulating an siRNA targeting heat shock protein 47 (HSP47), demonstrated significant anti-fibrotic effects in rat lung fibrosis models. The treatment led to dose-dependent reduction in collagen deposition, improvement in lung function, and downregulation of fibrosis-related genes. These results support the potential evaluation of ND-L02-s0201 in patients with idiopathic pulmonary fibrosis.

ERJ OPEN RESEARCH (2021)

Article Chemistry, Medicinal

Structure-Activity Relationship Study on Col-003, a Protein-Protein Interaction Inhibitor between Collagen and Hsp47

Masahito Yoshida et al.

CHEMICAL & PHARMACEUTICAL BULLETIN (2020)

Article Cell Biology

The multifaceted nature of αB-crystallin

Junna Hayashi et al.

CELL STRESS & CHAPERONES (2020)

Article Biochemistry & Molecular Biology

Small molecule inhibitor of HSP47 prevents pro-fibrotic mechanisms of fibroblasts in vitro

Takuto Miyamura et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)

Review Biochemistry & Molecular Biology

Extended Exhaled Nitric Oxide Analysis in Interstitial Lung Diseases: A Systematic Review

Paolo Cameli et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Biochemistry & Molecular Biology

Idiopathic Pulmonary Fibrosis and Lung Cancer: Mechanisms and Molecular Targets

Beatriz Ballester et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Review Medical Laboratory Technology

The double edge sword of fibrosis in cancer

Chelsea Chandler et al.

TRANSLATIONAL RESEARCH (2019)

Article Medicine, General & Internal

Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease

Oliver Distler et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Critical Care Medicine

Interstitial Lung Abnormalities and Lung Cancer Risk in the National Lung Screening Trial

Stacey-Ann Whittaker Brown et al.

CHEST (2019)

Article Medicine, General & Internal

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases

K. R. Flaherty et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Review Biochemistry & Molecular Biology

Roles of the endoplasmic reticulum-resident, collagen-specific molecular chaperone Hsp47 in vertebrate cells and human disease

Shinya Ito et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2019)

Review Respiratory System

Idiopathic Pulmonary Fibrosis and Lung Cancer A Systematic Review and Meta-analysis

Stacey-Ann Whittaker Brown et al.

ANNALS OF THE AMERICAN THORACIC SOCIETY (2019)

Review Medicine, General & Internal

Idiopathic Pulmonary Fibrosis

David J. Lederer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Review Oncology

The heat shock protein 47 as a potential biomarker and a therapeutic agent in cancer research

Beatriz Dal Pont Duarte et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)

Article Biochemistry & Molecular Biology

A small-molecule compound inhibits a collagen-specific molecular chaperone and could represent a potential remedy for fibrosis

Shinya Ito et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2017)

Review Cell Biology

Biology of Hsp47 (Serpin H1), a collagen-specific molecular chaperone

Shinya Ito et al.

SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2017)

Article Biochemistry & Molecular Biology

A Novel Antifibrotic Mechanism of Nintedanib and Pirfenidone

Larissa Knueppel et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2017)

Review Respiratory System

Idiopathic non-specific interstitial pneumonia

Elizabeth A. Belloli et al.

RESPIROLOGY (2016)

Review Critical Care Medicine

Acute Exacerbation of Idiopathic Pulmonary Fibrosis An International Working Group Report

Harold R. Collard et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)

Article Genetics & Heredity

Regulation of LOXL2 and SERPINH1 by antitumor microRNA-29a in lung cancer with idiopathic pulmonary fibrosis

Kazuto Kamikawaji et al.

JOURNAL OF HUMAN GENETICS (2016)

Article Toxicology

Emodin alleviates bleomycin-induced pulmonary fibrosis in rats

Ruijuan Guan et al.

TOXICOLOGY LETTERS (2016)

Review Cell Biology

Force Matters: Biomechanical Regulation of Cell Invasion and Migration in Disease

FuiBoon Kai et al.

TRENDS IN CELL BIOLOGY (2016)

Review Oncology

The biology and function of fibroblasts in cancer

Raghu Kalluri

NATURE REVIEWS CANCER (2016)

Review Rehabilitation

Size dependent classification of heat shock proteins: a mini-review

Hyunseok Jee

JOURNAL OF EXERCISE REHABILITATION (2016)

Article Critical Care Medicine

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis An Update of the 2011 Clinical Practice Guideline

Ganesh Raghu et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)

Review Respiratory System

Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis

Lutz Wollin et al.

EUROPEAN RESPIRATORY JOURNAL (2015)

Article Critical Care Medicine

Epidemiologic Survey of Japanese Patients with Idiopathic Pulmonary Fibrosis and Investigation of Ethnic Differences

Motoki Natsuizaka et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)

Article Biochemistry & Molecular Biology

Emodin Ameliorates LPS-Induced Acute Lung Injury, Involving the Inactivation of NF-κB in Mice

Min Xiao et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)

Article Medicine, General & Internal

A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

Talmadge E. King et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Medicine, General & Internal

Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

Luca Richeldi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Respiratory System

Serum heat shock protein 47 levels are elevated in acute interstitial pneumonia

Tomoyuki Kakugawa et al.

BMC PULMONARY MEDICINE (2014)

Article Pharmacology & Pharmacy

Antifibrotic and Anti-inflammatory Activity of the Tyrosine Kinase Inhibitor Nintedanib in Experimental Models of Lung Fibrosis

Lutz Wollin et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)

Article Respiratory System

Serum heat shock protein 47 levels in patients with drug-induced lung disease

Tomoyuki Kakugawa et al.

RESPIRATORY RESEARCH (2013)

Article Pharmacology & Pharmacy

Nanostructured Materials in Drug and Gene Delivery: A Review of the State of the Art

Kailash C. Petkar et al.

CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS (2012)

Article Biochemistry & Molecular Biology

Structural basis of fibrillar collagen trimerization and related genetic disorders

Jean-Marie Bourhis et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2012)

Article Multidisciplinary Sciences

Structural insights into triple-helical collagen cleavage by matrix metalloproteinase 1

Szymon W. Manka et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Article Cardiac & Cardiovascular Systems

HSP47 in lung fibroblasts is a predictor of survival in fibrotic nonspecific interstitial pneumonia

Misato Amenomori et al.

RESPIRATORY MEDICINE (2010)

Article Pathology

Localization of HSP47 mRNA in murine bleomycin-induced pulmonary fibrosis

Tomoyuki Kakugawa et al.

VIRCHOWS ARCHIV (2010)

Editorial Material Chemistry, Multidisciplinary

Impact of Nanotechnology on Drug Delivery

Omid C. Farokhzad et al.

ACS NANO (2009)

Article Biochemical Research Methods

Identification of Proteomic Differences between Squamous Cell Carcinoma of the Lung and Bronchial Epithelium

Gereon Poschmann et al.

MOLECULAR & CELLULAR PROTEOMICS (2009)

Article Critical Care Medicine

Epithelial endoplasmic reticulum stress and apoptosis in sporadic idiopathic pulmonary fibrosis

Martina Korfei et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)

Article Medicine, Research & Experimental

Pirfenidone inhibits the expression of HSP47 in TGF-β1-stimulated human lung fibroblasts

Seiko Nakayama et al.

LIFE SCIENCES (2008)

Article Medicine, Research & Experimental

Diallyl sulfide attenuates bleomycin-induced pulmonary fibrosis:: Critical role of iNOS, NF-κB, TNF-α and IL-1β

Srinivasan Kalayarasan et al.

LIFE SCIENCES (2008)

Article Medicine, Research & Experimental

Alpha-defensin enhances expression of HSP47 and collagen-1 in human lung fibroblasts

Sumako Yoshioka et al.

LIFE SCIENCES (2007)

Article Biochemistry & Molecular Biology

Nitric oxide in the pathogenesis of diffuse pulmonary fibrosis

Yi-Chiang Hsu et al.

FREE RADICAL BIOLOGY AND MEDICINE (2007)

Article Respiratory System

Expression of HSP47 in usual interstitial pneumonia and nonspecific interstitial pneumonia

T Kakugawa et al.

RESPIRATORY RESEARCH (2005)

Article Respiratory System

Pirfenidone attenuates expression of HSP47 in murine bleomycin-induced pulmonary fibrosis

T Kakugawa et al.

EUROPEAN RESPIRATORY JOURNAL (2004)

Article Physiology

Increased expression of collagen-binding heat shock protein 47 in murine bleomycin-induced pneumopathy

H Ishii et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2003)

Article Biochemistry & Molecular Biology

Prevalence of HSP47 antigen and autoantibodies to HSP47 in the sera of patients with mixed connective tissue disease

SI Yokota et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)

Article Multidisciplinary Sciences

Type I collagen is thermally unstable at body temperature

E Leikina et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)

Article Biochemistry & Molecular Biology

Structure-function studies on Hsp47:: pH-dependent inhibition of collagen fibril formation in vitro

CA Thomson et al.

BIOCHEMICAL JOURNAL (2000)

Review Medicine, General & Internal

Medical progress - The acute respiratory distress syndrome.

LB Ware et al.

NEW ENGLAND JOURNAL OF MEDICINE (2000)

Article Biochemistry & Molecular Biology

Structural basis of collagen recognition by integrin α2β1

J Emsley et al.